Navigation Links
Bend Research Named Large Distinguished Business of the Year by Bend Chamber of Commerce Membership
Date:6/29/2011

BEND, Ore., June 29, 2011 /PRNewswire-USNewswire/ -- Bend Research Inc. (www.bendresearch.com), a leading independent drug-formulation development and manufacturing company, has been named Large Distinguished Business of the Year by the Bend Chamber of Commerce membership.

The award was announced at the Chamber's annual SAGE Awards banquet in late May.

According to the Bend Chamber, the annual award recognizes the large business among the Bend Chamber membership that has "…a reputation for providing outstanding products and/or services to their customers."

The Chamber noted that Bend Research is a "…cornerstone of Central Oregon's high-tech industry, taking pride in improving human health through innovation as well as contributing to the next generation of scientists."

"We're very honored to receive this award from the Chamber," said Rod Ray, president and chief executive officer of Bend Research Inc. "Our Central Oregon roots are a big part of what this company is all about, so this recognition means a lot to us."

The SAGE Awards is a competitive process. Businesses are nominated and then voted on by the Bend Chamber membership. Other nominees in the large business category were Eberhard's Dairy Products, family-owned and operated since 1951; and Tomco Electric Inc., established in 1973.

The Bend Chamber is one of the largest and most active chambers in Oregon, representing 1,200 businesses with more than 23,000 employees. In addition to acknowledging a distinguished large business, the chamber also recognized Donner Flowers as the Small Distinguished Business of the Year; Saving Grace as the Outstanding Organization of the Year; and Oran Teater, business leader and former mayor of Bend, as Citizen of the Year.

About Bend Research Inc.

For more than 30 years, Bend Research has worked with clients to create value by advancing new medicines that improve human health and to solve their most difficult scientific and technical problems. This success is based on the company's ability to develop, advance, and commercialize pharmaceutical technologies. The firm's innovative drug-delivery solutions grow from a solid base of scientific and engineering fundamental understanding.

Bend Research provides formulation and dosage-form support, assists in process development and optimization, manufactures clinical-trial quantities of drug candidates in its cGMP facilities, and advances promising drug candidates from conception through commercialization. Bend Research is a leader in novel formulations, including solubilization technologies such as spray-dried dispersions and hot-melt extrusion formulations, as well as controlled-release, inhalation, and biotherapeutics technologies.

Bend Research has more than 200 employees based in four state-of-the-art facilities in Bend, Oregon, USA. For more information about Bend Research and the SAGE award, please contact Phoenix Ivers via email at Phoenix.Ivers@BendResearch.com or phone at 541-382-4100.


'/>"/>
SOURCE Bend Research Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Napoleone Ferrara Wins 2011 Dr. Paul Janssen Award for Biomedical Research
2. Advocates, 150 Children With Type 1 Diabetes Urge FDA to Enable Critical Research on Life-Saving Artificial Pancreas to Move Forward
3. Cepheid Appoints Vice President of Infectious Disease Research & Development
4. Study Identifies Large Concentration of Contract Research Assets in Kansas City Region
5. AlphaDetail, Healthcare Market Research Specialist, Named to the Honomichl Top 50
6. Research Finds Greater Focus on Self-Care Would Save Patients and U.S. Healthcare System Over $5 Billion Annually
7. Research Led by Clinical Nurse Specialists Reconfirms Reliability of Temporal Artery Thermometry
8. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
9. ViaCyte Names Michael Scott Vice President, Device Research & Development
10. Research 2.0 Updates Coverage of Viral Genetics with Research Report Focused on VG Energy
11. Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):